CB
LGND icon

Commerce Bank’s Ligand Pharmaceuticals LGND Stock Holding History

Commerce Bank’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$706K Buy
2,232
+430
+24% +$101K ﹤0.01% 855
2026
Q1 		$360K Buy
1,802
+494
+38% +$97.7K ﹤0.01% 1060
2025
Q4 		$247K Buy
+1,308
New +$251K ﹤0.01% 1146

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Commerce Bank's LGND Position: Q2 2026 in Review

Commerce Bank increased its Ligand Pharmaceuticals (LGND) stake by 24% in Q2 2026, buying an estimated $101K and bringing the position to 2,232 shares worth $706K. The position accounts for ﹤0.01% of the portfolio, ranked #855.

Commerce Bank first reported a position in LGND in Q4 2025 and has held it in 3 quarters since. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Commerce Bank held 2,232 shares of Ligand Pharmaceuticals worth $706K as of Q2 2026.
  • Commerce Bank bought 430 Ligand Pharmaceuticals shares in Q2 2026, an estimated $101K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #855 holding.
  • Commerce Bank first reported a position in Ligand Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.